From Structure–Activity to Structure–Selectivity Relationships: Quantitative Assessment, Selectivity Cliffs, and Key Compounds
暂无分享,去创建一个
[1] Tudor I. Oprea,et al. Quantifying the Relationships among Drug Classes , 2008, J. Chem. Inf. Model..
[2] J. Bajorath,et al. Methods for Computer‐Aided Chemical Biology. Part 3: Analysis of Structure–Selectivity Relationships through Single‐ or Dual‐Step Selectivity Searching and Bayesian Classification , 2008, Chemical biology & drug design.
[3] Mindy I. Davis,et al. A quantitative analysis of kinase inhibitor selectivity , 2008, Nature Biotechnology.
[4] Jürgen Bajorath,et al. Molecular similarity analysis uncovers heterogeneous structure-activity relationships and variable activity landscapes. , 2007, Chemistry & biology.
[5] H. Kubinyi. QSAR and 3D QSAR in drug design Part 1: methodology , 1997 .
[6] Mathias Wawer,et al. Navigating structure-activity landscapes. , 2009, Drug discovery today.
[7] J. Bajorath,et al. Structure-activity relationship anatomy by network-like similarity graphs and local structure-activity relationship indices. , 2008, Journal of medicinal chemistry.
[8] A. Hopfinger,et al. Methods for applying the quantitative structure-activity relationship paradigm. , 2004, Methods in molecular biology.
[9] Rajarshi Guha,et al. Structure-Activity Landscape Index: Identifying and Quantifying Activity Cliffs , 2008, J. Chem. Inf. Model..
[10] J. Bajorath,et al. Systematic computational analysis of structure-activity relationships: concepts, challenges and recent advances. , 2009, Future medicinal chemistry.
[11] David S. Munro,et al. In: Software-Practice and Experience , 2000 .
[12] John M. Barnard,et al. Chemical Similarity Searching , 1998, J. Chem. Inf. Comput. Sci..
[13] A. Hopkins. Network pharmacology: the next paradigm in drug discovery. , 2008, Nature chemical biology.
[14] G. V. Paolini,et al. Global mapping of pharmacological space , 2006, Nature Biotechnology.
[15] Jürgen Bajorath,et al. Structural Interpretation of Activity Cliffs Revealed by Systematic Analysis of Structure-Activity Relationships in Analog Series , 2009, J. Chem. Inf. Model..
[16] Jürgen Bajorath,et al. Molecular similarity analysis in virtual screening: foundations, limitations and novel approaches. , 2007, Drug discovery today.
[17] Francis L. Fennell. Hopkins , 2010 .
[18] Michael J. Keiser,et al. Relating protein pharmacology by ligand chemistry , 2007, Nature Biotechnology.
[19] J. Bajorath. Computational analysis of ligand relationships within target families. , 2008, Current opinion in chemical biology.
[20] Edward M. Reingold,et al. Graph drawing by force‐directed placement , 1991, Softw. Pract. Exp..
[21] Gerald M. Maggiora,et al. On Outliers and Activity Cliffs-Why QSAR Often Disappoints , 2006, J. Chem. Inf. Model..
[22] J. Bajorath,et al. SAR index: quantifying the nature of structure-activity relationships. , 2007, Journal of medicinal chemistry.